BIOCRYST TO RELEASE FIRST QUARTER 2005 FINANCIAL RESULTS ON APRIL 21, 2005
Birmingham, Alabama - April 14, 2005 - BioCryst Pharmaceuticals, Inc. (Nasdaq NM: BCRX) will release its financial results for the first quarter of 2005, and provide an update on the status of its programs, before the market opens on Thursday, April 21, 2005. The Company will also sponsor a conference call at 10:00 a.m. ET. Interested investors can listen to the call live over the Internet from the investor relations website at www.biocryst.com or by dialing 1-888-208-1814, and providing the passcode number 6428936.
What:
BioCryst Pharmaceuticals, Inc. First Quarter 2005 Financial Results Conference Call
When:
Thursday, April 21, 2005, 10:00 a.m., ET
Where:
http://phx.corporate-ir.net/playerlink.zhtml?c=74878&s=wm&e=1053006
How:
Live over the Internet -- Simply log on to the web at the address above, or
Live conference call -- Dial 1-888-208-1814, passcode 6428936.
Founded in 1986, BioCryst Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of small-molecule pharmaceuticals to treat cancer, cardiovascular and autoimmune diseases and viral infections.
For those unable to listen at the designated time, the webcast will remain available for replay over BioCryst's investor relations website until July 31, 2005. A conference call replay will also be available from approximately 1:00 p.m. ET on Thursday, April 21, 2005 through midnight Saturday, April 23, 2005 by dialing 1-888-203-1112 and entering passcode 6428936.
Contacts:
BioCryst Pharmaceuticals, Inc.
Michael A. Darwin
Chief Financial Officer
(205) 444-4600
Noonan/Russo
Sharon Weinstein (Investors)
(212) 845-4271
Wendy Lau (Media)
(212) 845-4272